Literature DB >> 25313

Characterization of the heterogeneous molecules of human interferons: differences in the cross-species antiviral activities of various molecular populations in human leukocyte interferons.

L S Lin, M Wiranowska-Stewart, T Chudzio, W E Stewart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 25313     DOI: 10.1099/0022-1317-39-1-125

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


× No keyword cloud information.
  8 in total

1.  Glycosylation of human leukocyte interferon: effects of tunicamycin.

Authors:  K C Chadha; P M Grob; R L Hamill; E Sulkowski
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

2.  Enzymatic modifications of human fibroblast and leukocyte interferons.

Authors:  M J Otto; J J Sedmak; S E Grossberg
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

3.  Production, purification and characterization of rat interferon.

Authors:  L S Lin; S L Abreu
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

4.  Monkey interferon: activity on human cells and chromatographic properties. Brief report.

Authors:  E Yakobson; M Revel; D Gurari-Rotman
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

5.  Inhibition of interferon secretion in human fibroblast by vinblastine.

Authors:  F H Sarkar; S L Gupta
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

6.  Biological properties of human interferon fractions obtained by blue sepharose chromatography.

Authors:  J S Erickson; B J Dalton; K Paucker
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

7.  Constitutive, long-term production of human interferons by hamster cells containing multiple copies of a cloned interferon gene.

Authors:  J Haynes; C Weissmann
Journal:  Nucleic Acids Res       Date:  1983-02-11       Impact factor: 16.971

8.  Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus.

Authors:  F A Ennis; A Meager
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.